ASN: Finerenone May Slow Progression in CKD With T2DM
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo
Only registered members have full access to PracticeUpdate content.